Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

March 22, 2024

Study Completion Date

March 22, 2024

Conditions
Chronic Diabetic Foot Ulcer
Interventions
DRUG

Fespixon Cream

"1. Name : Fespixon Cream~2. Dosage form: Topical cream, 15 g ointment per tube~3. Active ingredients: 1.25% extracts of Plectranthus amboinicus (PA-F4, 0.25%) and Centella asiatica (S1, 1%)~4. Dose(s): Apply 1 cc per 5 cm\^2 ulcer size (not exceeding 2 mm in thickness)~5. Dosing schedule: Apply twice a day~6. Duration: up to 20 weeks"

Trial Locations (1)

106

Cathay General Hospital, Taipei

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Oneness Biotech Co., Ltd.

INDUSTRY

lead

Cathay General Hospital

OTHER